BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 8008028)

  • 21. Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome.
    Montgomery RA; Geraghty MT; Bull E; Gelb BD; Johnson M; McIntosh I; Francomano CA; Dietz HC
    Am J Hum Genet; 1998 Dec; 63(6):1703-11. PubMed ID: 9837823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of microsatellite markers flanking FBN1: utility in the diagnostic evaluation for Marfan syndrome.
    Judge DP; Biery NJ; Dietz HC
    Am J Med Genet; 2001 Feb; 99(1):39-47. PubMed ID: 11170092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marfan's syndrome: an overview.
    Yuan SM; Jing H
    Sao Paulo Med J; 2010 Dec; 128(6):360-6. PubMed ID: 21308160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal diagnosis and a donor splice site mutation in fibrillin in a family with Marfan syndrome.
    Godfrey M; Vandemark N; Wang M; Velinov M; Wargowski D; Tsipouras P; Han J; Becker J; Robertson W; Droste S
    Am J Hum Genet; 1993 Aug; 53(2):472-80. PubMed ID: 8101042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Difficulties in diagnosing Marfan's syndrome in childhood and adolescence].
    Knirsch W; Haas NA; Bäuerle K; Uhlemann F
    Klin Padiatr; 2003; 215(5):262-7. PubMed ID: 14520587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of molecular analyses in the exploration of extreme intrafamilial variability in the Marfan syndrome.
    De Backer J; Loeys B; Leroy B; Coucke P; Dietz H; De Paepe A
    Clin Genet; 2007 Sep; 72(3):188-98. PubMed ID: 17718856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Case of congenital Marfan's syndrome].
    Gol'tiapin DB; Iagoda AV; Palekhova OIu
    Klin Med (Mosk); 1999; 77(11):55-6. PubMed ID: 10635638
    [No Abstract]   [Full Text] [Related]  

  • 28. Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome.
    Dietz HC; McIntosh I; Sakai LY; Corson GM; Chalberg SC; Pyeritz RE; Francomano CA
    Genomics; 1993 Aug; 17(2):468-75. PubMed ID: 8406497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A major involvement of the cardiovascular system in patients affected by Marfan syndrome: novel mutations in fibrillin 1 gene.
    Pepe G; Giusti B; Attanasio M; Comeglio P; Porciani MC; Giurlani L; Montesi GF; Calamai GC; Vaccari M; Favilli S; Abbate R; Gensini GF
    J Mol Cell Cardiol; 1997 Jul; 29(7):1877-84. PubMed ID: 9236141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular basis of Marfan syndrome.
    Maslen CL; Glanville RW
    DNA Cell Biol; 1993 Sep; 12(7):561-72. PubMed ID: 8397814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marfan's syndrome and other disorders of fibrillin.
    Francke U; Furthmayr H
    N Engl J Med; 1994 May; 330(19):1384-5. PubMed ID: 8152453
    [No Abstract]   [Full Text] [Related]  

  • 32. Clustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains.
    Dietz HC; Saraiva JM; Pyeritz RE; Cutting GR; Francomano CA
    Hum Mutat; 1992; 1(5):366-74. PubMed ID: 1301946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome.
    Milewicz DM; Grossfield J; Cao SN; Kielty C; Covitz W; Jewett T
    J Clin Invest; 1995 May; 95(5):2373-8. PubMed ID: 7738200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.
    De Backer J
    Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a Marfan cellular phenotype.
    Eldadah ZA; Brenn T; Furthmayr H; Dietz HC
    J Clin Invest; 1995 Feb; 95(2):874-80. PubMed ID: 7860770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Computer construction and analysis of protein models of mutant fibrillin-1 gene in Marfan's syndrome].
    Shentu XC; Tang XJ; Ye PP; Jin CF; Wang W; Yao K
    Zhonghua Yan Ke Za Zhi; 2009 Aug; 45(8):699-702. PubMed ID: 20021881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes.
    Lee B; Godfrey M; Vitale E; Hori H; Mattei MG; Sarfarazi M; Tsipouras P; Ramirez F; Hollister DW
    Nature; 1991 Jul; 352(6333):330-4. PubMed ID: 1852206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrillin abnormalities and prognosis in Marfan syndrome and related disorders.
    Aoyama T; Francke U; Gasner C; Furthmayr H
    Am J Med Genet; 1995 Aug; 58(2):169-76. PubMed ID: 8533811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations of extracellular matrix components in vascular disease.
    Ramirez F; Pereira L
    Ann Thorac Surg; 1999 Jun; 67(6):1857-8; discussion 1868-70. PubMed ID: 10391325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between psychiatric disorders and Marfan's syndrome in a large Sardinian family with a high prevalence of cardiac abnormalities.
    Mercuro G; Carpiniello B; Ruscazio M; Zoncu S; Montisci R; Rudas N; Cherchi A
    Clin Cardiol; 1997 Mar; 20(3):243-5. PubMed ID: 9068910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.